DEXCOM INC — Director's Dealing 2020

Nov 21, 2020

SEC Form 4/A — Form 4/A

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-11-19

Reporting Person: Stern Sadie (EVP Chief Human Resources Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-19	Common Stock	A	8207	—	Acquired	8207	Direct

Footnotes

F1: This amendment to Form 4 corrects the number of restricted stock units ("RSUs") granted and the date of grant as previously reported on Form 4 filed November 10, 2020. The correct date of grant for the RSUs is November 19, 2020 and the correct number of RSUs granted is 8,207.

F2: Represents a grant of RSUs that vest in four annual installments on November 19, 2021, November 19, 2022, November 19, 2023 and November 19, 2024. Share units represent a contingent right to receive one share of Dexcom, Inc. common stock upon settlement for no consideration.